Posttraumatic autotransplantation of spleen tissue

Archives of Surgery
S MizrahiB Shtamler

Abstract

Clinical and laboratory studies have documented high susceptibility to pneumococcal infection in asplenic humans and animals. Splenic autotransplantation has been suggested as a method of preserving function. Autotransplantation of irreparably damaged spleens in humans preserved splenic functions. Ten patients operated on for blunt abdominal trauma required unavoidable splenectomy. In each, autotransplantation of the removed spleen (roughly 50 g) was performed. Postoperative studies of splenic functions revealed disappearance of Howell-Jolly bodies from peripheral blood. Levels of IgM, which were initially significantly depressed, returned to normal and there were normal technetium Tc 99m sulfur colloid scans ten weeks after surgery. All patients are alive and healthy. Our data suggest that autotransplantation of spleen is a safe alternative method for preserving splenic function when total splenectomy is mandatory for hemostasis.

Citations

Mar 1, 1994·Annals of Surgery·P W Pisters, H L Pachter
Jun 27, 2013·World Journal of Gastroenterology : WJG·Giovanni TarantinoCarmine Finelli
Jan 1, 1992·Virchows Archiv. A, Pathological Anatomy and Histopathology·C Maesawa, T Sakuma
Dec 19, 2001·Current Problems in Surgery·A B PeitzmanR N Townsend
Jan 18, 2007·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Andrea BrendolanT Neil Dear
Sep 30, 2004·The Journal of Trauma·C Clay CothrenJeffrey L Johnson
Apr 1, 1996·The British Journal of Surgery·R LeemansH J Klasen
Oct 3, 2019·ANZ Journal of Surgery·Arthavan SurendranJulian Choi
Apr 19, 2003·Clinical Nuclear Medicine·Sami AjmiHabib Essabbah
Feb 17, 1997·Clinica Chimica Acta; International Journal of Clinical Chemistry·G HaklarA S Yalçin
Oct 28, 1997·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·M C Christo, L J DiDio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.